Hyderabad, June 6 -- Indian Immunologicals Limited (IIL), a leading biopharmaceutical company, has acquired the naming rights of the Madhapur Metro Station through a long-term agreement with L&T Metro Rail (Hyderabad) Limited, it was announced on Friday.
The station will now be known as Indian Immunologicals Limited Madhapur Metro Station.
At the naming rights inauguration ceremony here, K Anand Kumar, Managing Director of IIL, highlighted the company's role in making India self-sufficient in vaccine production and its commitment to sustainability and public health.
He noted that the collaboration supports eco-friendly public transport and aligns with IIL's "One Health" vision.
K V B Reddy, MD & CEO of L&T Metro Rail, praised IIL's con...